<p>Mice were treated with CD22-cal at days −6 and −1 and were immunized with 400 µg G6PI in complete Freund's adjuvant. Control mice were immunized but otherwise left untreated. Lymph nodes (LN), spleens and bone marrow were isolated, counted and analyzed for the percentage of CD19<sup>+</sup> B and CD3<sup>+</sup> T lymphocytes. Shown are the total number cells harvested (left) or the total number of B- (middle) or T-lymphocytes (right) in the various organs. Data are representative for at least three mice per time point.</p
<p>Panel A: Spleen (top) or LN (bottom) cells from representative B6 WT (WT), B6.<i>Baff<sup>−/−</su...
<p>FACS analysis was performed to assess B cell populations in the bone marrow (A), peripheral blood...
<p>On day 21 post IRBP<sub>1–20</sub> immunization, lymph nodes from control vehicle-administered mi...
<p>Eight week old female NOD mice were treated with 50 µg anti-CD20 and 7 days later various B-cell ...
<p>Spleens were harvested from CD19-Cre<sup>+</sup> SNAP-23<sup>fl/+</sup> control mice or CD19-Cre<...
<p>B220+ CD19+ cells were selected and quantified in uninfected wild typeWT and galectin-3−/− mice (...
a<p>Mice were treated with SU5416 (25 mg/kg/day) or equivalent amounts of vehicle control for 3 days...
<div><p>Cells were prepared from the lungs and spleens harvested from four uninfected naïve mice or ...
<p><b>A.</b> Treatment schedule. Hemophilia A (HA) mice in “αCD20” groups received a dose of 10 mg/k...
<p>Flow cytometric analysis of spleen, lymph node and blood from <i>Med23<sup>flox/flox</sup></i> an...
(A-B) 106 CD45.1 OT1 T cells were transferred i.v. into CD45.2+ mice, treated i.p. with 500μg of ant...
<p>A) Splenic cells of the indicated groups were stained with antibodies recognizing CD19 and IgM. P...
<p>(A) B cell numbers following CY or PBS treatment. Flow cytometry was performed to identify B (B22...
<p>Mice were treated with SU5416 (25 mg/kg/day) or equivalent amounts of vehicle. In separate experi...
<p>BALB/c mice were repeatedly injected with 50 µL of pyrogen-free saline (□) or 10 μg (protein) of ...
<p>Panel A: Spleen (top) or LN (bottom) cells from representative B6 WT (WT), B6.<i>Baff<sup>−/−</su...
<p>FACS analysis was performed to assess B cell populations in the bone marrow (A), peripheral blood...
<p>On day 21 post IRBP<sub>1–20</sub> immunization, lymph nodes from control vehicle-administered mi...
<p>Eight week old female NOD mice were treated with 50 µg anti-CD20 and 7 days later various B-cell ...
<p>Spleens were harvested from CD19-Cre<sup>+</sup> SNAP-23<sup>fl/+</sup> control mice or CD19-Cre<...
<p>B220+ CD19+ cells were selected and quantified in uninfected wild typeWT and galectin-3−/− mice (...
a<p>Mice were treated with SU5416 (25 mg/kg/day) or equivalent amounts of vehicle control for 3 days...
<div><p>Cells were prepared from the lungs and spleens harvested from four uninfected naïve mice or ...
<p><b>A.</b> Treatment schedule. Hemophilia A (HA) mice in “αCD20” groups received a dose of 10 mg/k...
<p>Flow cytometric analysis of spleen, lymph node and blood from <i>Med23<sup>flox/flox</sup></i> an...
(A-B) 106 CD45.1 OT1 T cells were transferred i.v. into CD45.2+ mice, treated i.p. with 500μg of ant...
<p>A) Splenic cells of the indicated groups were stained with antibodies recognizing CD19 and IgM. P...
<p>(A) B cell numbers following CY or PBS treatment. Flow cytometry was performed to identify B (B22...
<p>Mice were treated with SU5416 (25 mg/kg/day) or equivalent amounts of vehicle. In separate experi...
<p>BALB/c mice were repeatedly injected with 50 µL of pyrogen-free saline (□) or 10 μg (protein) of ...
<p>Panel A: Spleen (top) or LN (bottom) cells from representative B6 WT (WT), B6.<i>Baff<sup>−/−</su...
<p>FACS analysis was performed to assess B cell populations in the bone marrow (A), peripheral blood...
<p>On day 21 post IRBP<sub>1–20</sub> immunization, lymph nodes from control vehicle-administered mi...